Article Information
- Received February 24, 2004
- Revision received June 15, 2004
- Accepted June 15, 2004
- First published August 4, 2004.
- Version of record published August 4, 2004.
Author Information
- Lawrence Fourgeaud1,*,
- Susana Mato1,*,
- Delphine Bouchet2,
- Agnès Hémar2,
- Paul F. Worley3, and
- Olivier J. Manzoni1
- 1Equipe Institut National de la Santé et de la Recherche Médicale Avenir (Plasticité Synaptique: Maturation et Addiction), and 2Unité Mixte de Recherche, Centre National de la Recherche Scientifique 5091, Institut Magendie des Neurosciences, 33077 Bordeaux Cedex, France, and 3Department of Neuroscience, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287
Author contributions
Disclosures
- Received February 24, 2004.
- Revision received June 15, 2004.
- Accepted June 15, 2004.
Work in O.J.M.'s laboratory is supported by grants from Institut National de la Santé et de la Recherche Médicale (Programme Avenir), Ministère de la Recherche (Action Concerteé Incitative Jeune Chercheur), Fondation pour la Recherche Médicale, and Région Aquitaine. We thank Dr. D. Robbe for his participation in the initial phase of this project, Dr. Drago (Monash University, Victoria, Australia) for the D1R -/- mice that he generated, Dr. F. Gonon for housing and maintaining these mice in his laboratory, Dr. Ken Mackie for the generous gift of CB1R antibodies, and Drs. A. Schoepp and Monn at Eli Lilly for their generous gift of LY354740.
Correspondence should be addressed to Dr. O. Manzoni, Equipe Institut National de la Santé et de la Recherche Médicale, Avenir (Plasticité Synaptique: Maturation et Addiction), Rue Camille Saint Saëns, 33077 Bordeaux Cedex, France. E-mail: manzoni{at}bordeaux.inserm.fr.
Copyright © 2004 Society for Neuroscience 0270-6474/04/246939-07$15.00/0
↵* L.F. and S.M. contributed equally to this work.
